Log in to save to my catalogue

Fludarabine, busulfan, and melphalan conditioning regimen in allogeneic hematopoietic stem cell tran...

Fludarabine, busulfan, and melphalan conditioning regimen in allogeneic hematopoietic stem cell tran...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_94ac479f3e48422e8c85d2f38c9f67db

Fludarabine, busulfan, and melphalan conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with myeloid malignancies: A multicenter retrospective study

About this item

Full title

Fludarabine, busulfan, and melphalan conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with myeloid malignancies: A multicenter retrospective study

Publisher

United States: John Wiley & Sons, Inc

Journal title

EJHaem, 2024-08, Vol.5 (4), p.757-767

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Relapse remains the main cause of treatment failure in patients with myeloid malignancies even after allogeneic hematopoietic stem cell transplantation (allo‐HSCT). We observed a particularly low incidence of relapse in patients prepared with fludarabine, busulfan and melphalan in our previous study and this multicenter retrospective analysis aimed...

Alternative Titles

Full title

Fludarabine, busulfan, and melphalan conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with myeloid malignancies: A multicenter retrospective study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_94ac479f3e48422e8c85d2f38c9f67db

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_94ac479f3e48422e8c85d2f38c9f67db

Other Identifiers

ISSN

2688-6146

E-ISSN

2688-6146

DOI

10.1002/jha2.947

How to access this item